2 búsqueda de la palabra clave 'South America'

Melioidosis in South America / Franco Eduardo Montúfar Andrade    

Público ISBD Título : Melioidosis in South America Tipo de documento : documento electrónico Autores : Franco Eduardo Montúfar Andrade, Fecha de publicación : 2018 Títulos uniformes : Tropical Medicine and Infectious Disease Idioma : Inglés (eng) Palabras clave : Burkholderia pseudomallei  South America  melioidosis Resumen : Melioidosis is an emerging disease in the Americas. This paper reviews confirmed cases, the presence of Burkholderia pseudomallei and the organization of national surveillance policies for melioidosis in South America. Confirmed cases in humans have been reported from Ecuador, Venezuela, Colombia, Brazil, and Peru. The bacterium has been isolated from the environment in Brazil and Peru. The state of Ceará, northeastern region of Brazil, is the only place where specific public strategies and policies for melioidosis have been developed. We also discuss the urgent need for health authorities in South America to pay greater attention to this disease, which has the potential to have a high impact on public health, and the importance of developing coordinated strategies amongst countries in this region. Mención de responsabilidad : Dionne B Rolim, Rachel Ximenes R Lima, Ana Karoline C Ribeiro, Rafael M Colares, Leoniti D Q Lima, Alfonso J Rodríguez-Morales, Franco E Montúfar, David A B Dance Referencia : Trop Med Infect Dis. 2018 Jun 5;3(2). DOI (Digital Object Identifier) : 10.3390/tropicalmed3020060 PMID : 30274456 Derechos de uso : CC BY En línea : https://www.mdpi.com/2414-6366/3/2/60 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4695 Melioidosis in South America [documento electrónico] / Franco Eduardo Montúfar Andrade,  . - 2018. Obra : Tropical Medicine and Infectious Disease Idioma : Inglés (eng) Palabras clave : Burkholderia pseudomallei  South America  melioidosis Resumen : Melioidosis is an emerging disease in the Americas. This paper reviews confirmed cases, the presence of Burkholderia pseudomallei and the organization of national surveillance policies for melioidosis in South America. Confirmed cases in humans have been reported from Ecuador, Venezuela, Colombia, Brazil, and Peru. The bacterium has been isolated from the environment in Brazil and Peru. The state of Ceará, northeastern region of Brazil, is the only place where specific public strategies and policies for melioidosis have been developed. We also discuss the urgent need for health authorities in South America to pay greater attention to this disease, which has the potential to have a high impact on public health, and the importance of developing coordinated strategies amongst countries in this region. Mención de responsabilidad : Dionne B Rolim, Rachel Ximenes R Lima, Ana Karoline C Ribeiro, Rafael M Colares, Leoniti D Q Lima, Alfonso J Rodríguez-Morales, Franco E Montúfar, David A B Dance Referencia : Trop Med Infect Dis. 2018 Jun 5;3(2). DOI (Digital Object Identifier) : 10.3390/tropicalmed3020060 PMID : 30274456 Derechos de uso : CC BY En línea : https://www.mdpi.com/2414-6366/3/2/60 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4695

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD001169	AC-2018-108	Archivo digital	Producción Científica	Artículos científicos	Disponible

Documentos electrónicos

2018-108.pdf Adobe Acrobat PDF

Update of hepatitis C in Colombia / Juan Ignacio Marín Zuluaga ; Octavio Germán Muñoz Maya ; Juan Carlos Restrepo Gutiérrez ; Óscar Mauricio Santos Sánchez  

Público ISBD Título : Update of hepatitis C in Colombia Tipo de documento : documento electrónico Autores : Juan Ignacio Marín Zuluaga, ; Octavio Germán Muñoz Maya, ; Juan Carlos Restrepo Gutiérrez, ; Óscar Mauricio Santos Sánchez, Fecha de publicación : 2018 Títulos uniformes : Current Tropical Medicine Reports Dimensiones : PDF Idioma : Inglés (eng) Palabras clave : Hepatitis C  HCV  Colombia  South America  Direct-acting antiviral  DAA Resumen : Purpose of Review The goal is to describe the epidemiology, disease burden and detection, available therapies, and current challenges to access care for people with chronic hepatitis C infection in Colombia. Recent Findings There are no detailed statistics about the prevalence of HCVin Colombia; nonetheless, majority of patients with hepatitis C are infected with genotype 1 and having received blood products before 1996 represents the main risk factor. The use of intravenous drugs has started to be recognized as a population at risk that is in increment. Direct-acting antivirals became available in 2016 in Colombia thanks to a centralized purchase program with the Pan American Health Organization. Summary There are well-established guidelines for the use of available antivirals for all disease stages and genotypes and sustained virologic response (SVR) rates are 95 to 100%. Underdiagnosis, access and linkage to care, and disease stigmatization have contributed to a low number of patients that have actually completed their therapy. Mención de responsabilidad : Federico Hinestrosa, Juan Ignacio Marín, Octavio Muñoz Maya, Oscar Santos & Juan Carlos Restrepo Referencia : Curr Trop Med Rep (2018) 5: 133 DOI (Digital Object Identifier) : 10.1007/s40475-018-0147-5 En línea : https://link.springer.com/article/10.1007/s40475-018-0147-5 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3423 Update of hepatitis C in Colombia [documento electrónico] / Juan Ignacio Marín Zuluaga, ; Octavio Germán Muñoz Maya, ; Juan Carlos Restrepo Gutiérrez, ; Óscar Mauricio Santos Sánchez,  . - 2018 . -  ; PDF. Obra : Current Tropical Medicine Reports Idioma : Inglés (eng) Palabras clave : Hepatitis C  HCV  Colombia  South America  Direct-acting antiviral  DAA Resumen : Purpose of Review The goal is to describe the epidemiology, disease burden and detection, available therapies, and current challenges to access care for people with chronic hepatitis C infection in Colombia. Recent Findings There are no detailed statistics about the prevalence of HCVin Colombia; nonetheless, majority of patients with hepatitis C are infected with genotype 1 and having received blood products before 1996 represents the main risk factor. The use of intravenous drugs has started to be recognized as a population at risk that is in increment. Direct-acting antivirals became available in 2016 in Colombia thanks to a centralized purchase program with the Pan American Health Organization. Summary There are well-established guidelines for the use of available antivirals for all disease stages and genotypes and sustained virologic response (SVR) rates are 95 to 100%. Underdiagnosis, access and linkage to care, and disease stigmatization have contributed to a low number of patients that have actually completed their therapy. Mención de responsabilidad : Federico Hinestrosa, Juan Ignacio Marín, Octavio Muñoz Maya, Oscar Santos & Juan Carlos Restrepo Referencia : Curr Trop Med Rep (2018) 5: 133 DOI (Digital Object Identifier) : 10.1007/s40475-018-0147-5 En línea : https://link.springer.com/article/10.1007/s40475-018-0147-5 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3423

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD000757	AC-2018-044	Archivo digital	Producción Científica	Artículos científicos	Disponible